Andrew J Murphy
Co-Chief Scientific Officer · 1 filing · Latest: Oct 13, 2026
REGENERON PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
REGN | Andrew J Murphy | Co-Chief Scientific Officer | Oct 14, 2026 | Sale | $772.70 | 4,147 | $3.2M | 47,833 | |
REGN | Andrew J Murphy | Co-Chief Scientific Officer | Oct 13, 2026 | Option Exercise | $381.92 | 17,000 | $6.5M | 64,833 | |
REGN | MURPHY ANDREW J | — | Oct 14, 2026 | Proposed Sale | $772.70 | 4,147 | $3.2M | — |